関連レポート

ATPアッセイの世界市場：2028年に至る製品別、エンドユーザー別予測

出版元：Transparency Market Research  出版元について

発行年：2024年2月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 333ページになります。

商品コード：TMR228

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

マルチプレックスアッセイの世界市場規模は2022年で32億ドル、2031年に59億ドル、市場の平均年成長率は6.9%になる見込みです。

当レポートでは、マルチプレックスアッセイの市場予測-2031年、各種セグメント別市場分析(製品別、タイプ別、国地域別、等)、パイプライン分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■マルチプレックスアッセイの世界市場予測2017-2031年
・市場規模(US$)

■製品別、市場-2031年
器具
消耗品
・試薬/キット
・マイクロピペット/マイクロプレート
・その他

ソフトウェア
※(市場規模US$)

■技術別、市場-2031年
マルチプレックスRT-PCR
フローサイトメトリー
発光
蛍光
その他
※(市場規模US$)

■タイプ別、市場-2031年
タンパク質
・平面
・ビーズベース

核酸
・平面
・ビーズベース

細胞
※(市場規模US$)

■用途別、市場-2031年
研究/開発
・創薬研究
・バイオマーカー研究

診断
・感染症
・自己免疫疾患
・がん
・心血管疾患
・神経内分泌疾患
・その他

その他
※(市場規模US$)

■エンドユーザー別、市場-2031年
バイオテクノロジー/バイオ製薬会社
学術/研究センター
診断センター
病院
その他
※(市場規模US$)

■主要国地域別市場-2031年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
南米
・ブラジル、メキシコ
・その他南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス（促進要因、障壁、機会）
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析

■マルチプレックスアッセイの主要企業プロフィール動向
DiaSorin S.p.A.
Thermo Fisher Scientific, Inc.
Seegene, Inc.
Meso Scale Diagnostics, LLC
Abcam Limited
Bio-Rad Laboratories, Inc.
QIAGEN
Merck KGaA
Quansys Biosciences
Illumina, Inc.
（全333頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Multiplex Assays Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Multiplex Assays Market Analysis and Forecast, 2017-2031

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Multiplex Assays Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Instruments
6.3.2. Consumables
6.3.2.1. Reagents & Kits
6.3.2.2. Micropipettes & Microplates
6.3.2.3. Others
6.3.3. Software
6.4. Market Attractiveness, by Product

7. Global Multiplex Assays Market Analysis and Forecast, by Technology
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technology, 2017–2031
7.3.1. Multiplex RT-PCR
7.3.2. Flow Cytometry
7.3.3. Luminescence
7.3.4. Fluorescence
7.3.5. Others
7.3.6. Market Attractiveness, by Technology

8. Global Multiplex Assays Market Analysis and Forecast, By Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Type, 2017–2031
8.3.1. Protein
8.3.1.1. Planar
8.3.1.2. Bead-based
8.3.2. Nucleic Acid
8.3.2.1. Planar
8.3.2.2. Bead-based
8.3.3. Cell
8.4. Market Attractiveness, By Type

9. Global Multiplex Assays Market Analysis and Forecast, by Application
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Research & Development
9.3.1.1. Drug Discovery & Research
9.3.1.2. Biomarker Research & Application
9.3.2. Diagnosis
9.3.2.1. Infectious Diseases
9.3.2.2. Autoimmune Diseases
9.3.2.3. Cancer
9.3.2.4. Cardiovascular Diseases
9.3.2.5. Neuroendocrine Diseases
9.3.2.6. Others
9.3.3. Others
9.4. Market Attractiveness, by Application

10. Global Multiplex Assays Market Analysis and Forecast, by End-user
10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Biotechnology & Biopharmaceutical Companies
10.3.2. Academic & Research Centers
10.3.3. Diagnostic Centers
10.3.4. Hospitals
10.3.5. Others
10.4. Market Attractiveness, by End-user

11. Global Multiplex Assays Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region

12. North America Multiplex Assays Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Instruments & Software
12.2.2. Kits & Reagents
12.2.3. Services
12.3. Market Attractiveness, by Product
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Conventional PCR
12.4.2. Singleplex PCR
12.4.3. Multiplex PCR
12.4.4. Real-time PCR
12.4.5. Others
12.5. Market Attractiveness, by Technology
12.6. Market Value Forecast, By Type, 2017–2031
12.6.1. Protein
12.6.1.1. Planar
12.6.1.2. Bead-based
12.6.2. Nucleic Acid
12.6.2.1. Planar
12.6.2.2. Bead-based
12.6.3. Cell
12.7. Market Attractiveness, By Type
12.8. Market Value Forecast, by Application, 2017–2031
12.8.1. Companion Animal
12.8.2. Livestock Animal
12.9. Market Attractiveness, by Application
12.10. Market Value Forecast, by End-user, 2017–2031
12.10.1. Biotechnology & Biopharmaceutical Companies
12.10.2. Academic & Research Centers
12.10.3. Diagnostic Centers
12.10.4. Hospitals
12.10.5. Others
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017–2031
12.12.1. U.S.
12.12.2. Canada
12.13. Market Attractiveness Analysis
12.13.1. By Product
12.13.2. By Technology
12.13.3. By Type
12.13.4. By Application
12.13.5. By End-user
12.13.6. By Country

13. Europe Multiplex Assays Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Instruments
13.2.2. Consumables
13.2.2.1. Reagents & Kits
13.2.2.2. Micropipettes & Microplates
13.2.2.3. Others
13.2.3. Software
13.3. Market Attractiveness, by Product
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Multiplex RT-PCR
13.4.2. Flow Cytometry
13.4.3. Luminescence
13.4.4. Fluorescence
13.4.5. Others
13.5. Market Attractiveness, by Technology
13.6. Market Value Forecast, By Type, 2017–2031
13.6.1. Protein
13.6.1.1. Planar
13.6.1.2. Bead-based
13.6.2. Nucleic Acid
13.6.2.1. Planar
13.6.2.2. Bead-based
13.6.3. Cell
13.7. Market Attractiveness, By Type
13.8. Market Value Forecast, by Application, 2017–2031
13.8.1. Research & Development
13.8.1.1. Drug Discovery & Research
13.8.1.2. Biomarker Research & Application
13.8.2. Diagnosis
13.8.2.1. Infectious Diseases
13.8.2.2. Autoimmune Diseases
13.8.2.3. Cancer
13.8.2.4. Cardiovascular Diseases
13.8.2.5. Neuroendocrine Diseases
13.8.2.6. Others
13.8.3. Others
13.9. Market Attractiveness, by Application
13.10. Market Value Forecast, by End-user, 2017–2031
13.10.1. Biotechnology & Biopharmaceutical Companies
13.10.2. Academic & Research Centers
13.10.3. Diagnostic Centers
13.10.4. Hospitals
13.10.5. Others
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017–2031
13.12.1. Germany
13.12.2. U.K.
13.12.3. France
13.12.4. Italy
13.12.5. Spain
13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
13.13.1. By Product
13.13.2. By Technology
13.13.3. By Type
13.13.4. By Application
13.13.5. By End-user
13.13.6. By Country/Sub-region

14. Asia Pacific Multiplex Assays Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Instruments
14.2.2. Consumables
14.2.2.1. Reagents & Kits
14.2.2.2. Micropipettes & Microplates
14.2.2.3. Others
14.2.3. Software
14.3. Market Attractiveness, by Product
14.4. Market Value Forecast, by Technology, 2017–2031
14.4.1. Multiplex RT-PCR
14.4.2. Flow Cytometry
14.4.3. Luminescence
14.4.4. Fluorescence
14.4.5. Others
14.5. Market Attractiveness, by Technology
14.6. Market Value Forecast, By Type, 2017–2031
14.6.1. Protein
14.6.1.1. Planar
14.6.1.2. Bead-based
14.6.2. Nucleic Acid
14.6.2.1. Planar
14.6.2.2. Bead-based
14.6.3. Cell
14.7. Market Attractiveness, By Type
14.8. Market Value Forecast, by Application, 2017–2031
14.8.1. Research & Development
14.8.1.1. Drug Discovery & Research
14.8.1.2. Biomarker Research & Application
14.8.2. Diagnosis
14.8.2.1. Infectious Diseases
14.8.2.2. Autoimmune Diseases
14.8.2.3. Cancer
14.8.2.4. Cardiovascular Diseases
14.8.2.5. Neuroendocrine Diseases
14.8.2.6. Others
14.8.3. Others
14.9. Market Attractiveness, by Application
14.10. Market Value Forecast, by End-user, 2017–2031
14.10.1. Biotechnology & Biopharmaceutical Companies
14.10.2. Academic & Research Centers
14.10.3. Diagnostic Centers
14.10.4. Hospitals
14.10.5. Others
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017–2031
14.12.1. China
14.12.2. Japan
14.12.3. India
14.12.4. Australia & New Zealand
14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
14.13.1. By Product
14.13.2. By Technology
14.13.3. By Type
14.13.4. By Application
14.13.5. By End-user
14.13.6. By Country/Sub-region

15. Latin America Multiplex Assays Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Instruments
15.2.2. Consumables
15.2.2.1. Reagents & Kits
15.2.2.2. Micropipettes & Microplates
15.2.2.3. Others
15.2.3. Software
15.3. Market Attractiveness, by Product
15.4. Market Value Forecast, by Technology, 2017–2031
15.4.1. Multiplex RT-PCR
15.4.2. Flow Cytometry
15.4.3. Luminescence
15.4.4. Fluorescence
15.4.5. Others
15.5. Market Attractiveness, by Technology
15.6. Market Value Forecast, By Type, 2017–2031
15.6.1. Protein
15.6.1.1. Planar
15.6.1.2. Bead-based
15.6.2. Nucleic Acid
15.6.2.1. Planar
15.6.2.2. Bead-based
15.6.3. Cell
15.7. Market Attractiveness, By Type
15.8. Market Value Forecast, by Application, 2017–2031
15.8.1. Research & Development
15.8.1.1. Drug Discovery & Research
15.8.1.2. Biomarker Research & Application
15.8.2. Diagnosis
15.8.2.1. Infectious Diseases
15.8.2.2. Autoimmune Diseases
15.8.2.3. Cancer
15.8.2.4. Cardiovascular Diseases
15.8.2.5. Neuroendocrine Diseases
15.8.2.6. Others
15.8.3. Others
15.9. Market Attractiveness, by Application
15.10. Market Value Forecast, by End-user, 2017–2031
15.10.1. Biotechnology & Biopharmaceutical Companies
15.10.2. Academic & Research Centers
15.10.3. Diagnostic Centers
15.10.4. Hospitals
15.10.5. Others
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017–2031
15.12.1. Brazil
15.12.2. Mexico
15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
15.13.1. By Product
15.13.2. By Technology
15.13.3. By Type
15.13.4. By Application
15.13.5. By End-user
15.13.6. By Country/Sub-region

16. Middle East & Africa Multiplex Assays Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Product, 2017–2031
16.2.1. Instruments
16.2.2. Consumables
16.2.2.1. Reagents & Kits
16.2.2.2. Micropipettes & Microplates
16.2.2.3. Others
16.2.3. Software
16.3. Market Attractiveness, by Product
16.4. Market Value Forecast, by Technology, 2017–2031
16.4.1. Multiplex RT-PCR
16.4.2. Flow Cytometry
16.4.3. Luminescence
16.4.4. Fluorescence
16.4.5. Others
16.5. Market Attractiveness, by Technology
16.6. Market Value Forecast, By Type, 2017–2031
16.6.1. Protein
16.6.1.1. Planar
16.6.1.2. Bead-based
16.6.2. Nucleic Acid
16.6.2.1. Planar
16.6.2.2. Bead-based
16.6.3. Cell
16.7. Market Attractiveness, By Type
16.8. Market Value Forecast, by Application, 2017–2031
16.8.1. Research & Development
16.8.1.1. Drug Discovery & Research
16.8.1.2. Biomarker Research & Application
16.8.2. Diagnosis
16.8.2.1. Infectious Diseases
16.8.2.2. Autoimmune Diseases
16.8.2.3. Cancer
16.8.2.4. Cardiovascular Diseases
16.8.2.5. Neuroendocrine Diseases
16.8.2.6. Others
16.8.3. Others
16.9. Market Attractiveness, by Application
16.10. Market Value Forecast, by End-user, 2017–2031
16.10.1. Biotechnology & Biopharmaceutical Companies
16.10.2. Academic & Research Centers
16.10.3. Diagnostic Centers
16.10.4. Hospitals
16.10.5. Others
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017–2031
16.12.1. GCC Countries
16.12.2. South Africa
16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
16.13.1. By Product
16.13.2. By Technology
16.13.3. By Type
16.13.4. By Application
16.13.5. By End-user
16.13.6. By Country/Sub-region

17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. DiaSorin S.p.A.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Thermo Fisher Scientific, Inc.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Seegene, Inc.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Meso Scale Diagnostics, LLC
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. Abcam Limited
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. QIAGEN
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Bio-Rad Laboratories, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. Merck KGaA
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Quansys Biosciences
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Illumina, Inc.
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview

List of Tables

Table 01: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 03: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 04: Global Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017–2031

Table 05: Global Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Multiplex Assays Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 09: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 10: North America Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017–2031

Table 11: North America Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 12: North America Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 16: Europe Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017–2031

Table 17: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 18: Europe Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 21: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 22: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017–2031

Table 23: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Asia Pacific Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 27: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 28: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017–2031

Table 29: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 30: Latin America Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 31: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 33: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Technology, 2017–2031

Table 34: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, By Type, 2017–2031

Table 35: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 36: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Multiplex Assays Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Multiplex Assays Market Revenue (US$ Mn), by Product, 2022

Figure 03: Global Multiplex Assays Market Value Share, by Product, 2022

Figure 04: Global Multiplex Assays Market Revenue (US$ Mn), by Technology, 2022

Figure 05: Global Multiplex Assays Market Value Share, by Technology, 2022

Figure 06: Global Multiplex Assays Market Revenue (US$ Mn), By Type, 2022

Figure 07: Global Multiplex Assays Market Value Share, By Type, 2022

Figure 08: Global Multiplex Assays Market Revenue (US$ Mn), by Application, 2022

Figure 09: Global Multiplex Assays Market Value Share, by Application, 2022

Figure 10: Global Multiplex Assays Market Revenue (US$ Mn), by End-user, 2022

Figure 11: Global Multiplex Assays Market Value Share, by End-user, 2022

Figure 12: Global Multiplex Assays Market Value Share, by Region, 2022

Figure 13: Global Multiplex Assays Market Value (US$ Mn) Forecast, 2017–2031

Figure 14: Global Multiplex Assays Market Value Share Analysis, by Product, 2022–2031

Figure 15: Global Multiplex Assays Market Attractiveness Analysis, by Product, 2023–2031

Figure 16: Global Multiplex Assays Market Value Share Analysis, by Technology, 2022–2031

Figure 17: Global Multiplex Assays Market Attractiveness Analysis, by Technology, 2023–2031

Figure 18: Global Multiplex Assays Market Value Share Analysis, By Type, 2022–2031

Figure 19: Global Multiplex Assays Market Attractiveness Analysis, By Type, 2023–2031

Figure 20: Global Multiplex Assays Market Revenue (US$ Mn), by Application, 2022

Figure 21: Global Multiplex Assays Market Value Share, by Application, 2022

Figure 22: Global Multiplex Assays Market Revenue (US$ Mn), by End-user, 2022

Figure 23: Global Multiplex Assays Market Value Share, by End-user, 2022

Figure 24: Global Multiplex Assays Market Value Share Analysis, by Region, 2022–2031

Figure 25: Global Multiplex Assays Market Attractiveness Analysis, by Region, 2023–2031

Figure 26: North America Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 27: North America Multiplex Assays Market Attractiveness Analysis, by Country, 2023–2031

Figure 28: North America Multiplex Assays Market Value Share Analysis, by Country, 2022–2031

Figure 29: North America Multiplex Assays Market Value Share Analysis, by Product, 2022–2031

Figure 30: North America Multiplex Assays Market Value Share Analysis, by Technology, 2022–2031

Figure 31: North America Multiplex Assays Market Value Share Analysis, By Type, 2022–2031

Figure 32: North America Multiplex Assays Market Value Share Analysis, by Application, 2022–2031

Figure 33: North America Multiplex Assays Market Value Share Analysis, by End-user, 2022–2031

Figure 34: North America Multiplex Assays Market Attractiveness Analysis, by Product, 2023–2031

Figure 35: North America Multiplex Assays Market Attractiveness Analysis, by Technology, 2023–2031

Figure 36: North America Multiplex Assays Market Attractiveness Analysis, By Type, 2023–2031

Figure 37: North America Multiplex Assays Market Attractiveness Analysis, by Application, 2023–2031

Figure 38: North America Multiplex Assays Market Attractiveness Analysis, by End-user, 2023–2031

Figure 39: Europe Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 40: Europe Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 41: Europe Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 42: Europe Multiplex Assays Market Value Share Analysis, by Product, 2022–2031

Figure 43: Europe Multiplex Assays Market Value Share Analysis, by Technology, 2022–2031

Figure 44: Europe Multiplex Assays Market Value Share Analysis, By Type, 2022–2031

Figure 45: Europe Multiplex Assays Market Value Share Analysis, by Application, 2022–2031

Figure 46: Europe Multiplex Assays Market Value Share Analysis, by End-user, 2022–2031

Figure 47: Europe Multiplex Assays Market Attractiveness Analysis, by Product, 2023–2031

Figure 48: Europe Multiplex Assays Market Attractiveness Analysis, by Technology, 2023–2031

Figure 49: Europe Multiplex Assays Market Attractiveness Analysis, By Type, 2023–2031

Figure 50: Europe Multiplex Assays Market Attractiveness Analysis, by Application, 2023–2031

Figure 51: Europe Multiplex Assays Market Attractiveness Analysis, by End-user, 2023–2031

Figure 52: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 53: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 54: Asia Pacific Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 55: Asia Pacific Multiplex Assays Market Value Share Analysis, by Product, 2022–2031

Figure 56: Asia Pacific Multiplex Assays Market Value Share Analysis, by Technology, 2022–2031

Figure 57: Asia Pacific Multiplex Assays Market Value Share Analysis, By Type, 2022–2031

Figure 58: Asia Pacific Multiplex Assays Market Value Share Analysis, by Application, 2022–2031

Figure 59: Asia Pacific Multiplex Assays Market Value Share Analysis, by End-user, 2022–2031

Figure 60: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Product, 2023–2031

Figure 61: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Technology, 2023–2031

Figure 62: Asia Pacific Multiplex Assays Market Attractiveness Analysis, By Type, 2023–2031

Figure 63: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Application, 2023–2031

Figure 64: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by End-user, 2023–2031

Figure 65: Latin America Multiplex Assays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 66: Latin America Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 67: Latin America Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 68: Latin America Multiplex Assays Market Value Share Analysis, by Product, 2022–2031

Figure 69: Latin America Multiplex Assays Market Value Share Analysis, by Technology, 2022–2031

Figure 70: Latin America Multiplex Assays Market Value Share Analysis, By Type, 2022–2031

Figure 71: Latin America Multiplex Assays Market Value Share Analysis, by Application, 2022–2031

Figure 72: Latin America Multiplex Assays Market Value Share Analysis, by End-user, 2022–2031

Figure 73: Latin America Multiplex Assays Market Attractiveness Analysis, by Product, 2023–2031

Figure 74: Latin America Multiplex Assays Market Attractiveness Analysis, by Technology, 2023–2031

Figure 75: Latin America Multiplex Assays Market Attractiveness Analysis, By Type, 2023–2031

Figure 76: Latin America Multiplex Assays Market Attractiveness Analysis, by Application, 2023–2031

Figure 77: Latin America Multiplex Assays Market Attractiveness Analysis, by End-user, 2023–2031

Figure 78: Middle East & Africa Multiplex Assays Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 79: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 80: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 81: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Product, 2022–2031

Figure 82: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Technology, 2022–2031

Figure 83: Middle East & Africa Multiplex Assays Market Value Share Analysis, By Type, 2022–2031

Figure 84: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Application, 2022–2031

Figure 85: Middle East & Africa Multiplex Assays Market Value Share Analysis, by End-user, 2022–2031

Figure 86: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Product, 2023–2031

Figure 87: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Technology, 2023–2031

Figure 88: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, By Type, 2023–2031

Figure 89: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Application, 2023–2031

Figure 90: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by End-user, 2023–2031

△ 一番上に戻る